[1]王 洁.重组表皮因子受体抑制剂相关皮肤副反应[J].中国医学论坛报,2008,11(4):10.
[2]王 琳.西妥昔单抗联合化疗晚期结直肠癌的临床观察[J]. 临床肿瘤学杂志,2009,14(7):628-630.
[3]雍定丽. 西妥昔单抗联合化疗32例晚期肿瘤患者的毒副反应观察与护理[J]. 中华护理杂志,2009, 44(8):700-702.
[4]陕海丽. 特罗凯导致广泛皮疹及严重甲沟炎1例护理体会[J]. 中国人民武警医药杂志,2009,10(10):951-952.
[5]吴小君.碘伏治疗甲沟炎的效果观察[J].上海护理,2003,3(1):30.
[1]李丙军,丁江华,洪建明.卡培他滨节拍化疗治疗转移性结直肠癌22例[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):247.
[2]陈昌浩,孙岳军,王建东.受体酪氨酸激酶EphB6蛋白在结直肠癌中表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(04):346.[doi:10.3969/j.issn.1672-271X.2016.04.003]
CHEN Chang-hao,SUN Yue-jun,WANG Jian-dong..Clinical significance of decreased expression of EphB6 receptor tyrosine kinase in colorectal carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(04):346.[doi:10.3969/j.issn.1672-271X.2016.04.003]
[3]陈昕涛,高倩闽,李明明综述,等.个体化用药方案在结直肠癌患者化疗中的临床应用进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):65.[doi:10.3969/j.issn.1672-271X.2020.01.015]
CHENXin-tao,GAO Qian-min,LI Ming-ming reviewing,et al.Progress in clinical application of individualized drugs in the treatment of colorectal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(04):65.[doi:10.3969/j.issn.1672-271X.2020.01.015]
[4]陈昕涛综述,姚厚山审校.结直肠癌腹腔镜手术治疗的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):283.[doi:10.3969/j.issn.1672-271X.2020.03.013]
CHEN Xin-tao reviewing,YAO Hou-shan checking.Progress of laparoscopic surgery for colorectal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(04):283.[doi:10.3969/j.issn.1672-271X.2020.03.013]
[5]张嘉琦,贾佩琦,苏东明.染色盒同源物3对人结直肠癌细胞增殖的影响及其机制研究[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):6.[doi:10.3969/j.issn.1672-271X.2021.01.001]
ZHANG Jia-qi,JIA Pei-qi,SU Dong-ming.The effect of CBX3 on the biological behavior of human colorectal cancer cells and its mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(04):6.[doi:10.3969/j.issn.1672-271X.2021.01.001]